Greater than 25% absolute reduction in thrombotic events with CAD-1005 versus placebo on a background of standard anticoagulant therapy, despite no difference in platelet count recovery End-of-Phase 2 ...
Abstract: The necessity of lowering emissions in the transportation sector is driving growing interest in fuel cell electric vehicles (FCEVs). Nonetheless, these vehicles still face several challenges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results